However, whether Nav1.7 activated NHE to increase H+ efflux to provide a favorable environment for endometrial tumor invasion, or induced Ca2+-dependent signaling by stimulating NCX activity to accelerate development of endometrial cancer, remain unclear; further studies are required to address these uncertainties. The gene discussed is SLC9C1; the disease is endometrial cancer.